Health Law & Managed Care

Healthcare is an area of law that is constantly evolving, with the Affordable Care Act provisions still rippling through the industry, and privacy and data protection concerns requiring constant vigilance, the National Law Review covers the latest developments in the Health Care Industry. The National Law Review offers analysis of news coming out of Congress related to health care legislation, as well as covering state and local laws related to health care.

Readers will also find an extensive list of cases, news, and up-to-date information on various topics in the healthcare and managed care sector. Litigation, regulatory actions being taken against doctors or pharmacies, mediation and arbitration, and coverage of the latest in drug pricing, the opioid epidemic,  employer-healthcare coverage options, and legal news about health and hospital systems and physician groups.

The National Law Review covers news related to Medicare and Medicaid, to CMS funding, changes to IPAs, PHO, HMO, MSO, and other entities. Readers will find information related to managed care, assisted living facilities, at-home care, and news/legislation from the Office of the Inspector General (OIG) and the Office of the Federal Contract Compliance Programs (OFCCP). Additionally, regulations and updates released by the FDA are covered, as well as changing state and federal regulations related to telehealth and telemedicine are also on the site. 

Cybersecurity in health care and compliance with HIPAA are major concerns for the industry.  Additionally, Ransomware developments and other data security breaches have required a greater emphasis on safeguarding patient-records and information. More compliance and restrictions are in place for doctors/hospitals sharing patient records, HIPPA regulations have become more stringent, and e-health records, have seen a number of changes in how hospitals and doctors’ offices, deal with patient-record management internally. The National Law Review offers expert legal analysis on changing regulations related to healthcare.

For hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law Twitter feed and sign up for daily complimentary e-news bulletins.

Custom text Title Sort descending Organization
Aug
10
2021
21st Century Cures Act Information Blocking Rule: Innovative and In Effect Polsinelli PC
Jan
4
2017
21st Century Cures Act Lets Small Employers Reimburse Premiums Foley & Lardner LLP
Jul
6
2015
21st Century Cures Act on House Floor; CMS Proposes Modification to Two Midnight Rule, Publishes End-Stage Renal Disease PPS Proposed Rule; Supreme Court Upholds ACA Subsidies Squire Patton Boggs (US) LLP
Aug
3
2015
21st Century Cures Act Passes the House: Contains Key Provisions Related to Medical Devices Covington & Burling LLP
Dec
22
2016
21st Century Cures Act Provides Some Welcome Relief Foley & Lardner LLP
Dec
19
2016
21st Century Cures Act Requires FDA to Expand Role of Real World Evidence Mintz
Jun
10
2015
21st Century Cures Act with EHR and Telehealth Provisions Passes Through Committee with Flying Colors Covington & Burling LLP
Dec
9
2016
21st Century Cures Act Would Give Small Employers Greater Use of HRAs Jackson Lewis P.C.
Dec
16
2016
21st Century Cures Act: Small Employer Changes under the Affordable Care Act McDermott Will & Emery
Dec
15
2016
21st Century Cures Act’s Effect on Pharmaceutical and Biotechnology Industries Morgan, Lewis & Bockius LLP
Dec
5
2016
21st Century Cures Advances to Senate; Health Bills Scheduled for House Floor; MedPAC Meetings This Week Squire Patton Boggs (US) LLP
May
18
2015
21st Century Cures Legislation “Punts” on Telemedicine Mintz
Dec
8
2016
21st Century Cures: Congress Approves Legislation Expanding Hospital Site-Neutral Payment Exceptions and Making Other Payments Changes McDermott Will & Emery
Dec
10
2016
21st Century Cures: Congress Enacts Medicare Advantage and Small Business Insurance Market Reforms McDermott Will & Emery
Dec
15
2016
21st Century Cures: Examining Provisions for Streamlining FDA Regulations for Clinical Research in Title III McDermott Will & Emery
Jan
6
2017
21st Century Cures: Food and Drug Administration (FDA) Drug Provisions McDermott Will & Emery
Dec
13
2016
21st Century Cures: Health Information Technology and Digital Health Tool Provisions in Title IV McDermott Will & Emery
Dec
16
2016
21st Century Cures: Modernizing Public and Private Research McDermott Will & Emery
Dec
13
2016
21st Century Cures: Required Exploration of Telehealth Solutions McDermott Will & Emery
Dec
14
2016
21st Century Cures: Tackling Growing Problem of Mental Health and Substance Use Disorders McDermott Will & Emery
Sep
4
2018
23 Infants Contracted Infections at CHOP Stark & Stark
Nov
27
2013
23 Skidoo – Genomes, Gamesmanship and the First Amendment Faegre Drinker
Oct
12
2023
23andMe Confirms Threat Actors Accessed Accounts Without Authorization Robinson & Cole LLP
Aug
3
2015
25 Years of the ADA: Five Tips for ADA Compliance Foley & Lardner LLP
Jul
30
2015
2nd Circuit Upholds Connecticut State Dental Commission “Economic Protectionism” Barnes & Thornburg LLP
Jul
14
2022
3 Defense Strategies & 4 FAQs About Clinical Laboratory Investigation Cases Oberheiden P.C.
Sep
9
2016
3 Essential Steps For Responding To Ransomware Attacks Jackson Lewis P.C.
Nov
18
2014
3 Key P’S For Minimizing Liability For Employee Health Issues Barnes & Thornburg LLP
Feb
4
2020
3 Key Risk Management Responses to the Coronavirus Risk and Insurance Management Society, Inc. (RIMS)
Feb
19
2016
3 Takeaways from the Recent Ruling on Statistical Extrapolations in CMS Audits Polsinelli PC
Aug
24
2023
3 Tips to Reduce False Claims Act Exposure in the Wake of United States ex rel. Schutte v. SuperValu, Inc. Blank Rome LLP
Feb
24
2020
340B Ceiling Price Transparency – HRSA Now Requiring Pharmaceutical Manufacturers to Issue Refunds to Covered Entities for Overcharges Mintz
Aug
16
2017
340B Covered Entities Beware: CMS Proposes Drastic Drug Reimbursement Rate Cuts Polsinelli PC
Feb
2
2023
340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products McDermott Will & Emery
Mar
31
2020
340B COVID-19 Updates: HRSA COVID-19 Resources and Regulatory Flexibility Dinsmore & Shohl LLP
Apr
3
2019
340B Drug Ceiling Prices Now Available Dinsmore & Shohl LLP
Jul
2
2021
340B Drug Pricing Discount Program Update: HRSA Now Demands That Drug Manufacturers Provide 340B Discounts To Contract Pharmacies Amid Ongoing Litigation Sheppard, Mullin, Richter & Hampton LLP
Mar
19
2021
340B Drug Pricing Program 2021 Outlook [PODCAST] K&L Gates
Jan
4
2018
340B Drug Pricing Program Litigation Update Sheppard, Mullin, Richter & Hampton LLP
Jul
19
2018
340B Drug Pricing Program Litigation Update: American Hospital Association, Et Al. v. Azar Sheppard, Mullin, Richter & Hampton LLP
Jan
14
2019
340B Drug Pricing Program Litigation Update: Court Rejects CMS Drug Pricing Cuts Sheppard, Mullin, Richter & Hampton LLP
Mar
28
2013
340B Drug Pricing Program Notices on Group Purchasing Organizations and Medicaid Exclusion File McDermott Will & Emery
Feb
10
2017
340B Drug Pricing Program Omnibus Guidance Withdrawn Godfrey & Kahn S.C.
Apr
18
2016
340B Drug Pricing Program: HRSA Reopens Comment Period for 2015 Proposed Rule Squire Patton Boggs (US) LLP
Sep
15
2014
340B Federal Drug Pricing Program September Update: Self-Disclosures McDermott Will & Emery
Dec
19
2022
340B Hospital Reimbursement Update – Underpayments and the Need to Act Now Polsinelli PC
Jun
21
2022
340B Hospitals Win in Medicare OPPS Supreme Court Decision Foley & Lardner LLP
Mar
31
2021
340B in 2021: What Covered Entities and Their Partners Need to Know Now Recap McDermott Will & Emery
May
16
2019
340B In The Spotlight - Key Program Developments Polsinelli PC
Feb
28
2020
340B In The Spotlight – CMS 340B Acquisition Cost Survey Proposal & President’s Budget Polsinelli PC
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins